{"disease":{"id":"autoimmune-cytopenia","name":"autoimmune cytopenia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07175493","title":"A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":158,"lead_sponsor_name":"Keymed Biosciences Co.Ltd","has_results":false},{"nct_id":"NCT01667263","title":"The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04070599","title":"Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT03421184","title":"Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus","phase":"NA","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT07037732","title":"Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT04083014","title":"Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT00001630","title":"Treatment of Autoimmune Thrombocytopenia (AITP)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT06534021","title":"IASO-782 in Autoimmune Hematological Diseases","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":16,"lead_sponsor_name":"Shanghai IASO Biotechnology Co., Ltd","has_results":false},{"nct_id":"NCT06826430","title":"Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Juventas Cell Therapy Ltd.","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}